Experience Matters Most in MS Recruitment

Experience Matters Most in MS Recruitment

Multiple Sclerosis is a complex disease affecting an estimated 2.5 million people globally.  Thankfully, MS research is abundant, with 16 therapies approved by the FDA today and more than 30 in the pipeline.

Many challenges come with recruiting patients for MS clinical trials, but having extensive expertise to lean on can ease that burden. UBC’s Patient and Physician Services (PPS) team has supported every major MS drug in the clinical pipeline over the last 19 years.

Please watch the video below to hear Nancy Mulligan, Senior Operations Director of PPS, and her team, describe how we met enrollment goals for an MS clinical trial three weeks early.


Learn more from our MS experts, working in Clinical Development and Patient Access, and download information on UBC’s MS Recruitment Capabilities.

Contact us to put our clinical trial recruitment expertise to work for your next study.